Search results with tag "Biologics license application"
July 2021 GENERAL PRINCIPLES EMA-FDA PARALLEL …
www.ema.europa.euApplication in the United States, (b) the “applicant” that submits a New Drug Application or Biologics License Application in the United States, or (c) a potential marketing authorisation applicant under the marketing authorisation process in the European Union. 2. PSA requests should focus primarily on specific questions or issues ...
2020 HCPCS Application Summary - CMS
www.cms.govOct 01, 2020 · approved by the FDA under a Biologics License Application (BLA) on February 21, 2020 and is indicated for the preventive treatment of migraine in adults. VYEPTI (eptinezumab-jjmr) inhibits the activity of calcitonin gene-related peptide (CGRP), a neuropeptide known to play a key role in initiating and mediating migraine.
江苏恒瑞医药股份有限公司 - static.cninfo.com.cn
static.cninfo.com.cnAug 20, 2021 · BLA 指 生物制品执照申请（Biologics License Application） PCT 指 《专利合作条约》（Patent Cooperation Treaty） EHS 指 Environment、Health、Safety的缩写，EHS管理体系是环境管理体 系（EMS）和职业健康安全管理体系（OHSAS）两种体系的整合 SOP 指 标准 …
ACIP Data and Clinical Considerations for Additional Doses ...
www.cdc.govEUA= Emergency Use Authorization; BLA= Biologics License Application. Additional doses in immunocompromised people Review data: Assess safety, immunogenicity, and implementation . Regulatory allowance: EUA amendment would allow recommendations under EUA BLA would allow for ‘off label’
FAQS ABOUT AFFORDABLE CARE ACT IMPLEMENTATION …
www.cms.govOct 04, 2021 · under a BLA , and according to the scope of the applicable EUA or BLA. In a December 12, 2020 meeting, ACIP recommended : “For purposes of ACIP’s role under the Affordable Care Act, ACIP recommends use of COVID-19 vaccines within the scope of the Emergency Use Authorization or Biologics License Application for the particular vaccine.”2